Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Assets (2019 - 2025)

Historic Assets for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $104.5 million.

  • Eton Pharmaceuticals' Assets rose 19159.34% to $104.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.5 million, marking a year-over-year increase of 19159.34%. This contributed to the annual value of $76.1 million for FY2024, which is 13983.3% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Assets of $104.5 million as of Q3 2025, which was up 19159.34% from $101.7 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Assets high stood at $104.5 million for Q3 2025, and its period low was $21.5 million during Q3 2022.
  • Its 5-year average for Assets is $41.6 million, with a median of $30.9 million in 2023.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 2562.05% in 2022, then soared by 21950.48% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Assets (Quarter) stood at $27.5 million in 2021, then decreased by 8.87% to $25.0 million in 2022, then rose by 26.81% to $31.7 million in 2023, then soared by 139.83% to $76.1 million in 2024, then surged by 37.29% to $104.5 million in 2025.
  • Its last three reported values are $104.5 million in Q3 2025, $101.7 million for Q2 2025, and $84.0 million during Q1 2025.